AI could help doctors detect celiac disease during endoscopy

NCT ID NCT07387185

Recruiting now Diagnosis Sponsor: Istituti Clinici Scientifici Maugeri SpA Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether an artificial intelligence system can help doctors find signs of damage in the small bowel during endoscopy. The AI is trained to spot atrophy and other abnormalities linked to celiac disease and similar conditions. Researchers will compare the AI's accuracy to standard human review and biopsy results. The study involves 380 adults undergoing small bowel endoscopy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence system
What this could lead to: If successful, this AI could help doctors diagnose celiac disease and other gut conditions more accurately and quickly during endoscopy.
What could go wrong: This is an early-stage observational study, so the AI may not perform better than standard methods in real-world settings. It is not a treatment and does not directly benefit participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

celiac disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CELIAC DISEASE NON-CELIAC ENTEROPATHIES SMALL BOWEL MUCOSAL ATROPHY OR LESIONS

Contacts and locations

Locations

ICS Maugeri IRCCS
RECRUITING

Pavia, PV, 27100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.